Haynes Boone represented RedHill in the transaction. RedHill Biopharma Ltd. (NASDAQ: RDHL) announced an exclusive worldwide development and commercialization licensing agreement, excluding North America, for its…
RedHill’s Global Licensing Agreement with Hyloris

























